Search terms
Results 1 - 10 of 43 - ordered by :
Pages: 1 2 3 4 5 ... 5

The original JUPITER trial (2) was designed to answer the critical question of whether rosuvastatin prevents cardiovascular disease among healthy people with normal LDL cholesterol levels, but ...

Date : 23/07/2010

(1) More than 15,000 patients with chronic coronary heart disease provided information on their dental health, with results showing that indicators of periodontal disease (fewer remaining teeth, gum ...

Date : 10/04/2014

In the study published today, 4527 fit and healthy men and women with no history of cardiovascular or lung disease, cancer or raised blood pressure, had their cardiorespiratory fitness assessed when ...

Date : 29/11/2018

BARCELONA, Spain – Tuesday 2 September: One year of treatment with the highest dose of the cholesterol-lowering drug rosuvastatin can shrink plaque inside the arteries of patients who have had ...

Date : 02/09/2014

Wine only protects against cardiovascular disease (CVD) in people who exercise, according to results from the In Vino Veritas (IVV) study presented at ESC Congress today by Professor Milos Taborsky ...

Date : 31/08/2014

Doctor Jonathan Emberson, University of Oxford British Heart Foundation Senior Statistician, notes, “Statin therapy had no adverse effect on cancer at any site or in any group of individuals, ...

Date : 20/08/2010

Many NCDs share one or more common predisposing risk factors, all related to lifestyle in some degree; these include cigarette smoking, high blood pressure, high blood sugar levels, high cholesterol ...

Date : 02/07/2015

Dr Philippe Giral, an endocrinologist specialist in prevention of cardiovascular disease at Pitié-Salpêtrière Hospital (part of Assistance Publique-H ? itaux de Paris), Paris, ...

Date : 31/07/2019

Intima-media thickness (IMT) of the carotid artery can easily be evaluated by non-invasive ultrasound technique. Several studies have shown a significant relationship between IMT and cardiovascular ...

Date : 01/09/2008

First Joint ESC/EAS Guidelines for the Management of Dyslipidaemias In Europe, as many as one-half of patients are inadequately treated.1,2 The first European guidelines specifically focused on ...

Date : 28/06/2011